Vistagen Therapeutics, Inc. Common Stock Share Price
NASDAQ: VTGNHealthcare
Live Vistagen Therapeutics, Inc. Common Stock Share Price Chart
O H L
Vistagen Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$0.28Low
$0.29High
Markets Today
| Previous Close | $0.28 |
|---|---|
| Open | $0.29 |
| Volume | 1,066,778 |
| Day's Range | $0.28 - $0.29 |
| 52W Range | $0.20 - $5.14 |
| Market Cap | $12.54 M |
Historical Performance
| 1M Returns | +14.13 |
|---|---|
| 3M Returns | +12.90 |
| 6M Returns | -52.10 |
| 1Y Returns | -92.30 |
| 5Y Returns | -99.65 |
| 10Y Returns | -99.78 |
Vistagen Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $12.54 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.27 M |
| ROE TTM | -1.32 |
| EPS TTM | $-1.68 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.51 |
| EBITDA | $-71.93 M |
| Profit Margin | -5491.33 |
| Market Cap | $12.54 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.27 M |
| ROE TTM | -1.32 |
| EPS TTM | $-1.68 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.51 |
| EBITDA | $-71.93 M |
| Profit Margin | -5491.33 |
Vistagen Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | N/A | $244.00 K | $258.00 K | $303.00 K | $465.00 K | $1.48 M |
| Gross Profit + | N/A | $244.00 K | $258.00 K | $303.00 K | $465.00 K | $1.48 M |
| Operating Income | N/A | -$15.80 M | -$20.05 M | -$19.55 M | -$16.72 M | -$13.35 M |
| EBITDA | $40.00 K | -$15.76 M | -$20.00 M | -$19.49 M | -$16.66 M | -$13.30 M |
| Interest Expense | N/A | $0 | $0 | $0 | $2.44 M | $0 |
| Depreciation | - | $40.00 K | $53.00 K | $54.00 K | $52.00 K | $52.00 K |
| Income Before Tax | N/A | -$15.10 M | -$19.42 M | -$18.90 M | -$16.27 M | -$13.03 M |
| Income Tax Expense | N/A | $0 | $0 | $0 | $7.00 K | $0 |
| Net Income + | N/A | -$15.10 M | -$19.42 M | -$18.90 M | -$16.27 M | -$13.03 M |
| Net Profit Margin | - | -6186.48% | -7525.97% | -6237.29% | -3499.78% | -882.79% |
Vistagen Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $29.00 K | $29.00 K | $39.00 K | $40.00 K | $40.00 K | $44.00 K |
| Reserve & Surplus | -$407.63 M | -$422.73 M | -$442.13 M | -$461.03 M | -$477.32 M | -$490.35 M |
| Non-Current Liabilities | $1.34 M | $1.00 M | $946.00 K | $607.00 K | $249.00 K | $63.00 K |
| Current Liabilities | $12.61 M | $11.15 M | $13.64 M | $13.53 M | $12.79 M | $11.19 M |
| Total Liabilities | $13.95 M | $12.16 M | $14.59 M | $14.14 M | $13.04 M | $11.26 M |
| Fixed Assets | $476.00 K | $530.00 K | $516.00 K | $480.00 K | $427.00 K | $375.00 K |
| Current Assets | $82.08 M | $66.72 M | $78.93 M | $63.24 M | $46.94 M | $34.31 M |
| Total Assets | $84.34 M | $68.92 M | $80.93 M | $65.06 M | $48.56 M | $35.74 M |
Vistagen Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$13.63 M | -$15.10 M | -$19.42 M | -$18.90 M | -$16.27 M | -$13.03 M |
| Operating Cash Flow | -$10.06 M | -$18.85 M | -$13.76 M | -$17.63 M | -$16.20 M | -$14.71 M |
| Investing Cash Flow | $527.00 K | -$788.00 K | -$94.00 K | $104.00 K | -$99.00 K | $0 |
| Financing Cash Flow | $1.95 M | $1.49 M | $27.65 M | $2.11 M | -$283.00 K | $909.00 K |
| Change in Cash | -$7.58 M | -$18.15 M | $13.80 M | -$15.41 M | -$16.58 M | -$13.80 M |
Vistagen Therapeutics, Inc. Common Stock Return Calculator
The Vistagen Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$35
Invested Amount$10,000
Est. Returns$-9,965
About Vistagen Therapeutics, Inc. Common Stock
Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.
Popular Stocks
FAQs
What is the share price of Vistagen Therapeutics, Inc. Common Stock today?
Vistagen Therapeutics, Inc. Common Stock (VTGN) share price as of October 3, 2026 is $0.28. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Vistagen Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Vistagen Therapeutics, Inc. Common Stock (VTGN) Share by opening an international trading account with Angel One.
How can I purchase Vistagen Therapeutics, Inc. Common Stock shares in India?
Purchasing Vistagen Therapeutics, Inc. Common Stock (VTGN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Vistagen Therapeutics, Inc. Common Stock (VTGN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Vistagen Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Vistagen Therapeutics, Inc. Common Stock (VTGN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Vistagen Therapeutics, Inc. Common Stock?
The market capitalization of Vistagen Therapeutics, Inc. Common Stock on October 3, 2026, is $12.54 M.
In which sector Vistagen Therapeutics, Inc. Common Stock belongs?
Vistagen Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Vistagen Therapeutics, Inc. Common Stock stocks?
In order to invest in Vistagen Therapeutics, Inc. Common Stock (VTGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
